Загрузка...
Voriconazole Pharmacokinetics and Safety in Immunocompromised Children Compared to Adult Patients
The aim of this study was to investigate the pharmacokinetics and safety of voriconazole after intravenous (i.v.) administration in immunocompromised children (2 to 11 years old) and adults (20 to 60 years old) who required treatment for the prevention or therapy of systemic fungal infections. Nine...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology (ASM)
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2916341/ https://ncbi.nlm.nih.gov/pubmed/20547816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01731-09 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|